Thus, our results support the notion that manipulation of cMyBPC N-terminal phosphorylation has therapeutic potential for the treatment of HF and that this potential may extend to other truncated variants of cMyBPC that retain the M domain. This evidence concerns the gene MYBPC3 and hydrops fetalis.